5-hydroxymethylcytosine in HPV(+) and HPV(-) oral and oropharyngeal cancers
HPV( ) 和 HPV(-) 口腔癌和口咽癌中的 5-羟甲基胞嘧啶
基本信息
- 批准号:8958840
- 负责人:
- 金额:$ 23.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-07-01 至 2017-06-30
- 项目状态:已结题
- 来源:
- 关键词:AffectBioinformaticsBiological MarkersClinicalClinical DataCopy Number PolymorphismDNADNA MethylationDNA Sequence AlterationDataDatabasesDiagnosisDietEpidemiologyEpigenetic ProcessEventFreezingFutureGene ExpressionGenomeGenomicsGoalsGrantHPV-High RiskHead and Neck Squamous Cell CarcinomaHead and neck structureHigh-Throughput Nucleotide SequencingHuman PapillomavirusHuman papillomavirus 18LaboratoriesLeadLightLinkMalignant NeoplasmsMeasurementMeasuresMethodsMethylationMolecularMouth NeoplasmsNormal tissue morphologyOral cavityOropharyngealOropharyngeal NeoplasmsOropharyngeal Squamous Cell CarcinomaOutcomePatientsPatternPlayPopulationProcessPrognostic MarkerResearchRoleSample SizeSamplingSideSignal TransductionSiteSubgroupTestingThe Cancer Genome AtlasTissuesTobacco useTranscriptional RegulationTranslatingViralbasebead chipbisulfitebisulfite sequencingcarcinogenesisclinically relevantdeep sequencingdemethylationepigenomicsfollow-upgenome-wideinsightleukemiamalignant mouth neoplasmmalignant oropharynx neoplasmnoveloutcome forecastprogramspromoterpublic health relevanceresponsetargeted treatmenttooltranscriptome sequencingtranscriptomicstumor
项目摘要
DESCRIPTION (provided by applicant): Differences in molecular mechanisms between human papillomavirus (HPV)-induced oral cavity and oropharyngeal squamous cell carcinomas (OC/OP SCCs) and those associated with tobacco use lead to different responses to therapy, with patients having HPV-positive tumors having a better prognosis than those with HPV-negative tumors. We and others have shown that site-specific and global differences in DNA methylation exist between HPV(+) and HPV(-) tumors. 5-hydroxymethylcytosine (5hmC), once thought of as simply a transient step in the demethylation process, is now known to be aberrant with functional consequences in multiple cancers, however it has not yet been studied in OC/OP SCCs. Given suggestive evidence that 5hmC may also play a role in oral and oropharyngeal tumors, we propose to study 5hmC, its interactions with DNA methylation, and how these translate to functional changes in gene expression in HPV(+) and HPV(-) OC/OP SCCs. The goal of Aim 1 of this proposal will be to determine the extent and form of 5hmC involvement in HPV(+) and HPV(-) tumors by performing whole-genome 5hmC deep sequencing on a current set of OC/OP SCC frozen tumors and matched controls. In Aim 2, we will integrate the 5hmC data with whole-genome bisulfite sequencing data (which does not distinguish between 5hmC and 5mC marks), transcriptomics data measured via RNA-seq, and copy number variation data on the same tumors to determine how DNA methylation (5mC) and 5hmC deregulation affect the transcriptional programming in OC/OP SCCs and their relationship with clinical outcome. To help accomplish our goals, we will develop a bioinformatics method and tool for concurrent analysis and interpretation of 5mC and 5hmC deep sequencing data.
描述(由适用提供):人乳头瘤病毒(HPV)诱导的口腔和口咽型鳞状细胞癌(OC/OP SCC)与烟草使用相关的分子乳头瘤病毒(HPV)诱导的分子机制差异,导致对治疗的反应不同,导致对HPV稳定性肿胀的患者具有更好的预后症。我们和其他人表明,HPV(+)和HPV( - )肿瘤之间存在位点特异性和全局DNA甲基化的差异。 5-羟基甲基胞嘧啶(5HMC)曾经被认为仅仅是脱甲基化过程中的短暂步骤,现在已知在多种癌症中具有功能后果,但是在OC/OP SCC中尚未研究它。如果有暗示的证据表明5HMC也可能在口腔和口咽肿瘤中发挥作用,我们建议研究5HMC,其与DNA甲基化的相互作用,以及它们如何转化为HPV(+)和HPV( - )OC/OP/OP SCC中基因表达的功能变化。该提案的目标1的目的是通过在当前的OC/OP SCC冷冻肿瘤集和匹配的对照组上进行全基因组深度测序,以确定HPV(+)和HPV( - )肿瘤中5HMC参与的程度和形式。 In Aim 2, we will integrate the 5hmC data with whole-genome bisulfite sequencing data (which does not distinguish between 5hmC and 5mC marks), transcriptomics data measured via RNA-seq, and copy number variation data on the same tumors to determine how DNA methylation (5mC) and 5hmC deregulation affect the transcriptional programming in OC/OP SCCs and their relationship with clinical outcome.为了帮助实现我们的目标,我们将开发一种生物信息学方法和工具,用于同时分析和解释5MC和5HMC深度测序数据。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Maureen Agnes Sartor其他文献
Maureen Agnes Sartor的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Maureen Agnes Sartor', 18)}}的其他基金
Core 2: Immune Bioinformatics and Computational Biology Core
核心2:免疫生物信息学和计算生物学核心
- 批准号:
10478920 - 财政年份:2019
- 资助金额:
$ 23.55万 - 项目类别:
相似国自然基金
整合多层次组学数据发现复杂疾病标记物的生物信息学方法研究
- 批准号:61973190
- 批准年份:2019
- 资助金额:60 万元
- 项目类别:面上项目
基于全基因组测序建立病毒拷贝数和整合位点的生物信息学方法及数据分析
- 批准号:81770205
- 批准年份:2017
- 资助金额:55.0 万元
- 项目类别:面上项目
缺血性脑卒中康复期特异的复合生物标记模块筛选方法研究
- 批准号:61702496
- 批准年份:2017
- 资助金额:29.0 万元
- 项目类别:青年科学基金项目
基于定量蛋白质组学的鸡蛋储藏期间劣化分子机制研究
- 批准号:31772043
- 批准年份:2017
- 资助金额:60.0 万元
- 项目类别:面上项目
基于microRNA技术的精神分裂症相关生物标记物的遗传流行病学研究
- 批准号:81673253
- 批准年份:2016
- 资助金额:60.0 万元
- 项目类别:面上项目
相似海外基金
SEMA6D-mediated breast cancer disparity, metastasis, and tumor-immune interaction
SEMA6D 介导的乳腺癌差异、转移和肿瘤免疫相互作用
- 批准号:
10634959 - 财政年份:2023
- 资助金额:
$ 23.55万 - 项目类别:
Differentiating the biological effects of vaping from smoking by analyzing the methylome and transcriptome
通过分析甲基化组和转录组区分电子烟和吸烟的生物学效应
- 批准号:
10588059 - 财政年份:2023
- 资助金额:
$ 23.55万 - 项目类别:
tRNA-derived RNA Fragments (tRF) as Prognostic and Diagnostic Biomarkers for Alzheimer’s Disease
tRNA 衍生的 RNA 片段 (tRF) 作为阿尔茨海默病的预后和诊断生物标志物
- 批准号:
10578546 - 财政年份:2023
- 资助金额:
$ 23.55万 - 项目类别:
Pathways of Injury and Repair in Barrett's Carcinogenesis
巴雷特癌发生过程中的损伤和修复途径
- 批准号:
10713938 - 财政年份:2023
- 资助金额:
$ 23.55万 - 项目类别: